Editas Medicine Inc (EDIT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EDIT Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Editas Medicine Inc's financial stability and long-term positioning.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent123.65
Marketable Securities, Current SH0.00
Cash & Short-term Investments123.00
Accounts receivable2.59
Prepaid Expense And Other Assets Current1.83
Total Current Assets128.07
Equipment/Property/Plant Net2.88
Other Assets, Noncurrent18.39
Total Assets149.34
Liabilities
Accounts Payable, Current AC4.33
Accrued Liabilities, Current AC21.25
Long-term Debt, Current Maturities LO7.50
Other Liabilities, Current6.70
Total Current Liabilities39.78
Long-term debt47.18
Total Long-term Debt47.18
Other liabilities, Noncurrent57.97
Contract With Customer Liability Noncurrent44.51
Contract With Customer Liability Current-
Total Liabilities144.93
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,657.88
Retained Earnings / Accumulated Deficit-1,653.49
Other Equity0.00
Common Stockholder's Equity4.41
Total Stockholder's Equity4.41
Liabilities & Stockholder's Equity149.34
4 historic quarters locked

Sign in to unlock the full Editas Medicine Inc balance sheet history.

About Editas Medicine Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001650664-26-000083

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.